Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma [NA]
Completed clinical trial evaluating proton beam irradiation for unresectable hepatocellular carcinoma and cholangiocarcinoma, with results p…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Sorafenib and TRC105 in Hepatocellular Cancer [Phase 1, Phase 2]
This document reports the completion and posted results of a Phase 1/Phase 2 trial evaluating sorafenib in combination with TRC105 for hepat…
-
CLINICAL_TRIALS trial_result · 2018-01-17Clinical Trial Update: Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma [Phase 4]
Phase 4 clinical trial update assessing safety and efficacy of doxorubicin-eluting beads embolization in patients with advanced hepatocellul…
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) [Phase 1, Phase 2]
Clinical trial update for Resminostat (YHI-1001) in combination with Sorafenib in Asian patients with advanced hepatocellular carcinoma (HCC…
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma [Phase 3]
Phase 3 clinical trial update for single-session combined locoregional therapies in hepatocellular carcinoma (liver cancer).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer [Phase 2]
Phase 2 study of palbociclib (PD-0332991) in advanced hepatocellular carcinoma has completed with results posted (2018-01-05).
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma. [Phase 3]
Phase 3 trial update investigating low molecular weight heparin (LMWH) for preventing thromboembolic complications after transarterial chemo…
-
FDA approval · 2017-12-22FDA Approved: NEXAVAR — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
The FDA approved a supplemental application for Nexavar (sorafenib) submitted by Bayer HealthCare Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2017-12-21Clinical Trial Update: A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis [Phase 4]
A Phase 4 trial comparing surgery with sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study) [Phase 2]
Phase 2 clinical trial evaluating concurrent transarterial chemoembolization (TACE) and sorafenib for hepatocellular carcinoma with metastas…
-
CLINICAL_TRIALS trial_result · 2017-12-12Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma [Phase 3]
A Phase 3 study evaluating an all-oral regimen of ombitasvir/paritaprevir/ritonavir with or without dasabuvir and with or without ribavirin …
-
CLINICAL_TRIALS research · 2017-12-11Clinical Trial Update: The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial. [Phase 3]
A Phase 3 randomized trial evaluating whether neo-adjuvant transarterial chemoinfusion improves survival for patients with hepatocellular ca…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Metabolic Signature of Healthy Lifestyle and HCC
Clinical trial NCT03356535, sponsored by the International Agency for Research on Cancer, has completed a study examining the metabolic sign…
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: Interest of Functional MRI (Magnetic Resonance Imagery) (in Patients Suffering From Hepatocellular Carcinoma and Treated With Yttrium [NA]
A completed clinical trial evaluating functional MRI in patients with hepatocellular carcinoma treated with Yttrium-90.
-
CLINICAL_TRIALS trial_result · 2017-11-22Clinical Trial Update: 11C-acetate for Treatment Response After Radiotherapy for HCC [Phase 2]
Phase 2 study evaluating 11C-acetate as an imaging biomarker to assess treatment response after radiotherapy in hepatocellular carcinoma was…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients [Phase 1]
Phase I study evaluating ABT-888 (veliparib) with temozolomide in patients with various cancers, including metastatic melanoma. The trial st…
-
CLINICAL_TRIALS trial_result · 2017-11-21Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Primary Liver Cancer [Phase 2]
Phase 2 trial of antineoplaston therapy for hepatocellular carcinoma was terminated. No efficacy results are provided.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: A Phase I Study of Pazopanib in Adult Patients With Liver Cancer [Phase 1]
Phase I trial evaluating pazopanib in adults with hepatocellular carcinoma has been completed, focusing on safety, tolerability, and dosing.
-
CLINICAL_TRIALS withdrawal · 2017-11-17Clinical Trial Update: Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis. [NA]
A clinical trial comparing non-selective beta blockers to endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleedi…
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Caphosol in Oral Mucositis Due to Targeted Therapy [Phase 3]
A Phase 3 trial evaluating Caphosol for oral mucositis caused by targeted cancer therapies has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-13Clinical Trial Update: Residual Plasma Concentration of Sorafenib and Adverse Events in CHC
The update discusses residual plasma concentrations of sorafenib and related adverse events in patients with advanced or metastatic hepatoce…
-
CLINICAL_TRIALS trial_result · 2017-11-09Clinical Trial Update: Pembrolizumab as Neoadjuvant Treatment in HCC [Phase 2]
Phase 2 trial assessing pembrolizumab as neoadjuvant therapy for hepatocellular carcinoma. Sponsor: Kindai University; current trial status …
-
CLINICAL_TRIALS research · 2017-11-09Clinical Trial Update: Standard of Care Versus Hemopatch® During Liver Resection [NA]
This document describes a clinical trial comparing standard of care versus Hemopatch during liver resection, with the trial status listed as…
-
CLINICAL_TRIALS research · 2017-11-09Clinical Trial Update: Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma
A clinical trial update exploring whether LDH levels predict treatment outcomes in hepatocellular carcinoma.
-
CLINICAL_TRIALS trial_result · 2017-11-08Clinical Trial Update: Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) [Phase 2]
A completed Phase 2 clinical trial evaluated the combination of oblimersen and doxorubicin in patients with advanced hepatocellular carcinom…